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Abstract
Introduction: Access to lifesaving prevention of mother-to-child transmission (PMTCT) services 
is problematic in rural Zambia. The simplest intervention used in Zambia has been 2-dose 
nevirapine (NVP) administration in the peripartum period, a regimen of 1 NVP tablet to the 
mother at the onset of labor and 1 dose in the form of syrup to the newborn within 4 to 72 hours 
after birth. This 2-dose regimen has been shown to reduce MTCT by nearly 50%. We set out to 
demonstrate that in-home HIV testing and NVP dosing by traditional birth attendants (TBAs) is 
feasible and acceptable by women in rural Zambia.
Methods: This was a pilot program using TBAs to perform rapid saliva-based HIV testing and 
administer single-dose NVP in tablet form to the mother at the onset of labor and syrup to the 
infant after birth.
Results: A total of280 pregnant women were consented and enrolled into the program, of whom 
124 (44.3%) gave birth at home with the assistance of a trained TBA. Of those, 16 (12.9%) were 
known to be HIV positive, and 101 of the remaining 108 (93.5%) accepted a rapid HIV test. All 
these women tested HIV negative. In the subset of 16 mothers who were HIV positive, 13 (81.3%) 
took single-dose NVP administered by a TBA between 1 and 24 hours prior to birth and 100% of 
exposed newborns (16 of 16) received NVP syrup within 72 hours after birth, 80% of whom were 
dosed in the first 24 hours of life.
Discussion: With the substantial shortage of human resources in public health care throughout 
sub-Saharan Africa, it is extremely valuable to utilize lay health care workers to help extended 
services beyond the level of the facility. Given the high uptake of PMTCT services we believe that 
TBAs with proper training and support can successfully provide country-approved PMTCT.
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Pediatric HIV is a major cause of morbidity and mortality among young children in 
resource-limited settings with a high prevalence of HIV. Globally, an estimated 2.5 million 
children are currently infected with HIV, with 1000 children newly infected every day, 90% 
resulting from vertical transmission of the virus from mother to child at the time of birth.1
The main barrier in many low-resource areas, specifically African countries, is providing 
prevention of mother-to-child transmission (PMTCT) services to women in need. A study 
conducted in Rwanda showed that in the absence of PMTCT interventions, an estimated 
30,000 infants would contract HIV from their mothers each year.2 Unlike in adults, 
progression to AIDS in infants can be rapid. Without treatment, 30% of children born with 
HIV die before their first birthday, whereas 50% die before they turn 2 years of age.3,4
It is estimated that up to 45% of mothers with HIV in Zambia will transmit the virus to their 
exposed newborns if they do not receive any PMTCT intervention.3 However, vertical 
transmission of HIV can be substantially reduced with the administration of antiretroviral 
drugs.5 Prior to the national guideline changes in 2010, the standard of care and most widely 
practiced intervention used in Zambia was 2-dose nevirapine (NVP) administration in the 
peripartum period, a regimen of 1 NVP tablet to the mother at the onset of labor and 1 dose 
in the form of syrup to the infant within 4 to 72 hours after birth.6 Phase 1 studies have 
shown that rapid absorption of single-dose (200 mg) NVP taken by a pregnant woman at the 
onset of labor, more than 1 hour prior to birth, can travel rapidly through the placental 
membranes and reach concentrations in the newborn necessary to decrease vertical 
transmission of the virus by 50%.7–10 Because a single 200-mg dose of NVP has a reported 
half-life of 45 hours,11–14 the dose to the infant 4 to 72 hours after birth is necessary to 
extend the concentration of the drug in the infant’s system long enough for the mother-infant 
pair to reach a health facility for further care and treatment.13 If the mother receives the 
dose of NVP less than 1 hour prior to birth or not at all, the risk of vertical transmission to 
the infant increases, even if the infant is given the NVP syrup in a timely manner.13 In 2010 
the national PMTCT guidelines became more complex for pregnant women who test 
positive or seroconvert after 28 weeks’ gestation.15 This more complex regimen is highly 
effective in lowering transmission rates to 2% or less13 but can be considerably more 
difficult to implement in rural Zambia.
Currently, Zambia is among the 25 countries with highest estimated numbers of pregnant 
women living with HIV who are in need of antiretrovirals to prevent vertical transmission of 
the virus.1 However, access to care is problematic, especially in rural areas. One potential 
solution to this problem is training traditional birth attendants (TBAs) to implement at the 
community level one component of the PMTCT guidelines and standard of care available at 
the time of our study (single-dose NVP tablet and syrup6). This concept is logical for 2 
reasons. First, up to 40% of all HIV pediatric infections occur during birth.4 Second, most 
PMTCT programs in Zambia are currently based at health centers and facilities, yet an 
estimated 50% to 60% of infants born in rural communities are born at home with TBAs or 
family members.6
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We report here on a pilot program training TBAs to perform rapid HIV testing and 
administer single-dose NVP in tablet form to the mother and syrup to the infant for births 
occurring outside health facilities in rural Zambia. Our aim was to demonstrate the 
feasibility and effectiveness of using TBAs to administer a rapid saliva-based HIV test at the 
onset of labor and provide 2-dose peripartum NVP to mothers and and their infants born at 
home, which, at the time of our study, was part of the national PMTCT guidelines and the 
standard of care in Zambia.
METHODS
Traditional Birth Attendant Prevention of Mother-to-Child Transmission Pilot Program 
Setting
Access to health services in the Chikankata catchment area in Mazabuka District is limited 
because of sparse population densities, poor road networks, and limited staffing in health 
facilities. In addition, some parts of the catchment area are inaccessible, particularly during 
the rainy season, as flooding isolates some villages for at least 2 months of the year. 
Currently, only the central area (composed of the mission hospital, a few shops, the main 
high school, the biomedical and nurse training schools, and the parliamentary constituency 
office) is connected to the national electricity power grid. The Chikankata catchment area 
has one main hospital, the Chikankata Mission, which is supported by the Salvation Army, 
and there are 6 rural health centers that are all Zambian government facilities. The rural 
health centers are on average 25 kilometers from the referral mission hospitals.
Few of the rural health centers in the Chikankata catchment area have a complete 
complement of health staff (clinical officer, environmental health technician, nurse, and 
nurse-midwife). A clinical officer is a midlevel practitioner of medicine qualified to perform 
general medical duties such as diagnosing and treating disease and injury, ordering and 
interpreting medical tests, and performing routine medical and surgical procedures. The 
environmental health technician is trained to provide health education, safe water, and 
sanitation programs to the community. The nurse and nurse-midwife are both trained to treat 
patients and educate the community on various medical conditions; however, the nurse-
midwife has additional training in obstetrics. All services for children under 5 years of age 
and pregnant women at the mission hospitals and rural health centers are free of charge.
We chose to implement this pilot study in the Chikankata area because it is representative of 
many rural communities in Zambia and has a strong group of TBAs who are spread out 
geographically to adequately cater to their respective communities.
Ethical approval of the pilot program was granted by the ERES Converge Ethical Review 
Board in Lusaka, Zambia, and the Boston University institutional review board, with final 
clearance from the Ministry of Health in Zambia.
Overview of Traditional Birth Attendant Prevention of Mother-to-Child Transmission Pilot 
Program
The TBA PMTCT pilot program, implemented from February 2009 to July 2010, sought to 
demonstrate the feasibility and effectiveness of using TBAs to administer a rapid saliva-
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based HIV test (OraQuick, OraSure) late in pregnancy and to provide 2-dose peripartum 
NVP to mothers and their infants born at home.
All pregnant women in the Chikankata catchment area were approached by data collectors 
employed by the study and asked for their consent to participate in the pilot program at any 
point during their pregnancy prior to the onset of labor. Consent in this context did not refer 
to whether a given mother accepted or declined the HIV testing and NVP dosing because we 
could not control where she gave birth to her infant. Therefore, when we sought her consent 
to participate, she was consenting for us to collect data on her and her infant and the services 
they received before, during, and after birth. Our participation rates among women were 
high (99.6%); only 1 woman withdrew from the study after consenting (0.4%). Pregnant 
women were not given any incentive to be involved in the study. Because we collected 
demographic information on TBAs in addition to asking them about the care they provided 
prior to, during, and after labor, they were considered program participants. Thus, consent 
was obtained from them during the initial PMTCT training to allow us to collect data on 
them. No TBAs eligible to be involved in the pilot program declined participation.
At the time of the implementation of the program, there were 48 TBAs in the Chikankata 
catchment area. All were TBAs who had successfully completed a 6-week Ministry of 
Health TBA training course in antenatal care, family planning, birth management, 
counseling (on nutrition, danger signs, and prenatal care at the clinics), health education, 
antepartum maternal uterine growth and infant growth monitoring, home-based care, 
postnatal care, and referrals to local health clinics for necessary treatment. Because of 
budgetary constraints and the exclusion of TBAs who were illiterate, only 23 of the 48 TBAs 
were chosen to be involved in our program and went on to successfully complete the training 
for the implementation of the TBA PMTCT pilot program. The training involved 2 main 
components: 1) a weeklong refresher course based on the national PMTCT training for 
professional health care workers, which covered the essential elements of HIV and AIDS; 
and 2) a 4-day enhanced training course on how to use the OraQuick HIV test and how to 
administer NVP to a mother and child.
Traditional birth attendants who completed the study training were equipped with bicycles, 
clean birth kits (containing a plastic sheet for the mother to lie on, a piece of soap, a pair of 
gloves, gauze squares, cord ties, and a sterile scalpel blade), and kits containing rapid saliva-
based HIV tests (OraQuick) and NVP tablets (200 mg) for mothers with HIV and NVP 
syrup (prepackaged syringes containing individual 15-mg doses) for their exposed infants. 
Program supervisors tracked and replaced the number of HIV saliva test kits, NVP pills, and 
NVP syrup syringes used by each TBA on a monthly basis. Both the OraQuick HIV rapid 
test and the NVP tablets and syrup can be stored unopened at a temperature no higher than 
30° C. The OraQuick test has a shelf-life of 6 months. It has been evaluated in diverse 
settings and has shown high sensitivity (99.1%) and specificity (99.6%) for HIV antibody in 
both whole blood and oral fluid specimens.14
In the community, each TBA offered HIV volunteer counseling and testing to all mothers 
whose HIV status was unknown. If the mother had been previously tested at an antenatal 
clinic (ANC), her HIV status was noted on her ANC card, a document that all TBAs 
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currently use during all stages of their routine care for pregnant women or women who gave 
birth recently If at the onset of labor, the mother’s HIV status was unknown or negative, 
according to the mother or her ANC card, the TBAs offered her an OraQuick test. If the 
mother agreed to be tested and her HIV status was positive or if she was known positive 
based on her ANC card, the TBA administered NVP to the mother during labor and to the 
HIV-exposed infant immediately after birth. The TBAs then referred all women who were 
HIV positive to the nearest health facility for confirmatory testing, counseling on HIV, and 
the standard of care for follow-up of exposed infants. All mothers and infants, regardless of 
HIV status, were referred for postnatal follow-up and care at the local health centers, as is 
the standard of care in Zambia.
RESULTS
A total of 280 pregnant women were consented and enrolled into the pilot program. Of those 
280 women, 124 (44.3%) gave birth at home with the assistance of a study TBA and were 
the focus of the pilot program (Figure 1). Of the 124 women, 16 (12.9%) were known to be 
HIV positive based on their ANC card; 101 of the remaining 108 (93.5%) accepted the 
OraQuick test. All these women tested HIV negative.
In the subset of 16 mothers who were known to be HIV positive and gave birth at home, 13 
(81.3%) took single-dose NVP administered by a TBA between 1 and 24 hours prior to birth 
and 100% of the exposed newborns (16 of 16) received NVP syrup within 72 hours after 
birth, 80% of whom were dosed in the first 24 hours of life. All mothers and infants who 
took NVP received the drugs from a TBA except for 1 mother-infant pair who obtained both 
the single-dose NVP and the syrup from the local health center. Three women who were 
HIV positive did not receive single-dose NVP because 1) the TBA arrived late, resulting in 
the OraQuick test being done after birth and NVP syrup given only to the newborn; 2) the 
woman went into premature labor (25 weeks’ gestation); and 3) the woman declined to tell 
the TBA her HIV status until after the child was born.
DISCUSSION
Traditional birth attendants have been successfully assisting mothers to give birth to children 
in sub-Saharan Africa for millennia. Some argue that TBAs are often closer and more 
influential within their communities than formally trained health care staff because they 
usually speak the local language, are more affordable, provide essential social support 
during childbirth, and have the trust and respect of local community members.16–19 In 
resource-limited settings, TBAs already attend to a large portion of births and could be used 
to further expand the availability of certain PMTCT services to mothers and children in 
need.20
Our pilot study demonstrates that point-of-care testing and NVP dosing in the home by 
TBAs are feasible and adequately capture the large number of women who give birth outside 
health facilities. Ideally, skilled birth attendants should attend births, but this is an 
unforeseeable goal in most African countries because of challenges in training adequate 
numbers of skilled birth attendants and providing adequate facilities within these small 
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isolated villages where women will continue to live and give birth. This study demonstrates 
that in these situations, point-of-care service such as HIV testing and NVP dosing can be 
provided to the mother and newborn. In this study, more than 90% of women with unknown 
or HIV-negative status accepted a rapid saliva-based HIV test at the onset of labor, and more 
than 80% of mothers with HIV and 100% of their infants received NVP in a manner timely 
enough to lower the risk of vertical transmission of the virus to the infant. These results help 
to confirm the value of extending PMTCT services beyond health facilities and training a 
cadre of women who are well respected and accepted in the community.
Since the completion of our study, the government of Zambia, through its Ministry of 
Health, has adopted more efficacious PMTCT regimens based on World Health Organization 
recommendations15 in further attempts to reduce the burden of HIV from mother-to-child 
transmission. The current antiretroviral therapy (ART) regimens are highly complex for 
pregnant women who test positive or seroconvert after 28 weeks’ gestation, consisting of 
300 mg of zidovudine (AZT) to be taken twice daily during the antenatal period, 200-mg 
single-dose NVP at the onset of labor along with 150 mg of lamivudine and 300 mg of AZT 
to be repeated every 12 hours until birth, and lamivudine (150 mg) coupled with AZT (300 
mg) twice daily for 7 days postnatally. In addition, all HIV-exposed breastfeeding infants 
must be started on daily NVP prophylaxis (dose ranges from 10 to 15 mg depending on 
infant weight) from birth and continued throughout the duration of breastfeeding, whereas 
HIV-exposed non-breastfeeding infants must also be started on daily NVP from birth but 
only up until 6 weeks of age. All exposed infants must also be started on co-trimoxazole (40 
mg) from 6 weeks until HIV status is confirmed negative.15 We recognize the change in the 
guidelines as a limitation to the generalizability of our results; however, at the time of our 
study, 2-dose NVP was one of the recommended and most widely used PMTCT strategies. 
More importantly, we were able to demonstrate that TBAs can feasibly implement of the 
national guidelines for PMTCT prevention strategies, and we do not see any reason why 
TBAs would not be equally effective in implementing more efficacious regimens in future 
PMTCT programs in settings similar to Zambia.
Although the government of Zambia is no longer focused on empowering TBAs to 
administer drugs, the proven commitment of these women could be crucial in the 
government’s efforts to increase adherence to antiretrovirals among women and their infants 
late in pregnancy and after birth while the mother is breastfeeding, a period when the risk is 
known to be the highest.5 Zambia’s 2010 guidelines for PMTCT state that lay health care 
workers, such as TBAs, are to fill more of an educator’s role about basic knowledge and 
skills related to HIV/AIDS and PMTCT, such as encouraging pregnant women to go for 
early antenatal booking by 14 weeks’ gestation and to give birth in health care facilities.15 
One aspect of the government guidelines is focused on TBAs providing support for women 
and their infants to adhere to ART and to co-trimoxazole for pneumocystis pneumonia 
prophylaxis. As more efficacious PMTCT regimens are adopted nationally in countries such 
as Zambia, adherence to more complex drug regimens and medication dosing schedules 
becomes increasingly more important for such programs to be effective.
Resistance to NVP after a single dose in women and children with HIV is a major concern 
and not something we evaluated in this pilot study Results of a meta-analysis estimated that 
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approximately 30% of women and more than half of children who became HIV infected 
despite PMTCT intervention measures developed NVP resistance mutations after single-
dose NVP intake.22 Providing women and children in our study with the recommended 
standard of care for PMTCT likely led to NVP resistance but at the same time prevented 
transmission of HIV from mother to child, which was the primary focus of the program.
Our findings should be considered alongside their limitations. First, our lack of a 
comparison group, dropped early on because of funding restrictions, and the cross-sectional 
design prevent us from assessing the impact of the TBA pilot program on specific outcome 
indicators (ie, increase in the uptake of NVP among mother-infant pairs). However, we 
believe that the high acceptance of the OraQuick test among mothers who had negative or 
unknown HIV status around the time of birth and the high uptake of NVP among mothers 
with HIV and their exposed infants during the peripartum period are adequate process 
indicators. Second, Chikankata, although representative of many rural communities in 
Zambia, does have slightly better infrastructure and a potentially stronger community of 
literate TBAs than many rural areas, making a program like this potentially more difficult to 
implement in areas that are not comparable. Third, one characteristic that may be necessary 
for TBAs to adopt these practices would be literacy. Because TBAs were chosen on the basis 
of their level of literacy and had to be limited to 23 because of a restricted budget, the results 
of this pilot program may not be generalizable to TBAs who are illiterate. Because they need 
to be able to attend multiple training sessions (national PMTCT training for professional 
health care workers and 4-day enhanced training on how to use the OraQuick HIV test and 
how to administer NVP to a mother and child), women who were chosen needed to be 
literate in their local language. Fourth, we recognize that a woman actually receiving 
postpartum follow-up care is reflective of the mother’s situation and understanding, as well 
as the influence of the TBA and facility staff. Sixteen women with HIV and their infants in 
our pilot program were referred to their local health clinic for necessary care; however, 
because our study ended at the point of referral to the clinic, we cannot report on whether 
they received follow-up services. Fifth, we recognize that one of the main barriers to 
accessing proper care during labor and birth is the lack of affordable transportation (cars, 
bicycles, ambulances, etc) either for the pregnant woman to access the health facility or for 
the TBA to attend a home birth in a timely manner. Communication between the women and 
the TBAs was highlighted as a limiting factor in our study. There were 166 women (59.5%) 
of 279 who gave birth at home. In 31 of those births (18.7%), the mothers either gave birth 
alone or with a family member’s assistance. When the woman gave birth without assistance 
from a TBA, close to 90% of the time, it was because the mother or family did not inform 
the TBA that she was in labor, making it impossible for the TBA to attend the birth.
Two recent reviews stated that community-based solutions are essential to ensure that both 
women and their children have access to the full cascade of PMTCT interventions.23,24 The 
PMTCT programs that do not extend beyond facilities and fail to engage lay staff will not be 
able to achieve the level of PMTCT coverage required to decrease vertical transmission from 
mother to child.25,26 Although there is no research supporting TBAs administering the 
current more complex PMTCT treatments, research has shown that TBAs have been 
successful in providing lifesaving interventions along with administering and monitoring 
adherence to treatment regimens that are far more complex than a single oral dose of NVP to 
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a mother and her infant. The results from a randomized controlled trial conducted in the 
Lufwanyama District in Zambia’s Copperbelt Province showed that TBAs were able to 
effectively administer simple interventions (neonatal triage, prevention of hypothermia, and 
resuscitation) that helped to reduce neonatal mortality.27 Some TBAs have also been trained 
in various resource-limited settings to deliver tuberculosis treatment and monitor adherence, 
a complex regimen that takes up to 6 to 8 months to complete,28,29 and prophylaxis for 
malaria prevention to pregnant women.30
With the rapid growth in access to antiretrovirals for mothers and infants, we cannot ignore 
the critical shortage of health care workers in many resource-limited settings heavily 
burdened by the HIV epidemic. Despite the 2010 PMTCT guideline changes, 50% of 
women in rural Zambia are still giving birth at home. In many rural areas, TBAs are often 
the only caregivers willing and available to assist mothers before, during, and after birth. 
Traditional birth attendants provided with enhanced training along with ongoing supervision 
and support31 could successfully deliver certain PMTCT services to women and infants in 
need,32 ultimately providing an efficient, cost-effective33 intervention to reduce infant and 
child deaths from HIV and AIDS infection and extended PMTCT services beyond 
government facilities.
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• Our pilot study demonstrates that point-of-care testing and nevirapine dosing 
in the home by traditional birth attendants is feasible and adequately captures 
the large number of women who give birth outside health facilities.
• Traditional birth attendants provided with enhanced training along with 
ongoing supervision and support could successfully deliver certain prevention 
of mother-to-child HIV transmission services to women and infants in need.
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